124 related articles for article (PubMed ID: 8049646)
1. Cellular characteristics of acute myeloblastic leukemia associated with t(8;21)(q22;q22). The Japanese Cooperative Group of Leukemia/Lymphoma.
Kita K; Shirakawa S; Kamada N
Leuk Lymphoma; 1994 Apr; 13(3-4):229-34. PubMed ID: 8049646
[TBL] [Abstract][Full Text] [Related]
2. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34.
Kita K; Nakase K; Miwa H; Masuya M; Nishii K; Morita N; Takakura N; Otsuji A; Shirakawa S; Ueda T
Blood; 1992 Jul; 80(2):470-7. PubMed ID: 1378322
[TBL] [Abstract][Full Text] [Related]
3. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
4. Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO.
Da Silva N; Meyer-Monard S; Menot ML; Parrado A; Lebel A; Balitrand N; Fenaux P; Micléa JM; Rousselot P; Degos L; Dombret H; Chomienne C
Hematol J; 2000; 1(5):316-28. PubMed ID: 11920209
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.
Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H
Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630
[TBL] [Abstract][Full Text] [Related]
6. Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia.
de Greef GE; Hagemeijer A; Morgan R; Wijsman J; Hoefsloot LH; Sandberg AA; Sacchi N
Leukemia; 1995 Feb; 9(2):282-7. PubMed ID: 7869765
[TBL] [Abstract][Full Text] [Related]
7. Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies.
Zent C; Rowley JD; Nucifora G
Leukemia; 1997 Apr; 11 Suppl 3():273-8. PubMed ID: 9209363
[TBL] [Abstract][Full Text] [Related]
8. Effect of histone deacetylase inhibitor valproic acid on progenitor cells of acute myeloid leukemia.
Bug G; Schwarz K; Schoch C; Kampfmann M; Henschler R; Hoelzer D; Ottmann OG; Ruthardt M
Haematologica; 2007 Apr; 92(4):542-5. PubMed ID: 17488665
[TBL] [Abstract][Full Text] [Related]
9. Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21).
Porwit-MacDonald A; Janossy G; Ivory K; Swirsky D; Peters R; Wheatley K; Walker H; Turker A; Goldstone AH; Burnett A
Blood; 1996 Feb; 87(3):1162-9. PubMed ID: 8562943
[TBL] [Abstract][Full Text] [Related]
10. Leukemia-targeting ligands isolated from phage-display peptide libraries.
Jäger S; Jahnke A; Wilmes T; Adebahr S; Vögtle FN; Delima-Hahn E; Pfeifer D; Berg T; Lübbert M; Trepel M
Leukemia; 2007 Mar; 21(3):411-20. PubMed ID: 17252013
[TBL] [Abstract][Full Text] [Related]
11. The AML1 and ETO genes in acute myeloid leukemia with a t(8;21).
Nucifora G; Rowley JD
Leuk Lymphoma; 1994 Aug; 14(5-6):353-62. PubMed ID: 7812194
[TBL] [Abstract][Full Text] [Related]
12. Translocation t(8;21)(q22;q22): cytogenetics and molecular biology.
Berger R
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S67-9. PubMed ID: 8177719
[TBL] [Abstract][Full Text] [Related]
13. Expression of B cell-specific activator protein/PAX5 in acute myeloid leukemia with t(8;21)(q22;q22).
Valbuena JR; Medeiros LJ; Rassidakis GZ; Hao S; Wu CD; Chen L; Lin P
Am J Clin Pathol; 2006 Aug; 126(2):235-40. PubMed ID: 16891199
[TBL] [Abstract][Full Text] [Related]
14. Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2.
Kohzaki H; Ito K; Huang G; Wee HJ; Murakami Y; Ito Y
Oncogene; 1999 Jul; 18(28):4055-62. PubMed ID: 10435586
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemias with chromosomal abnormalities involving the 21q22 region identified by their in vitro responsiveness to interleukin-5.
Touw I; Donath J; Pouwels K; van Buitenen C; Schipper P; Santini V; Hagemeijer A; Löwenberg B; Delwel R
Leukemia; 1991 Aug; 5(8):687-92. PubMed ID: 1715959
[TBL] [Abstract][Full Text] [Related]
16. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children.
Hurwitz CA; Raimondi SC; Head D; Krance R; Mirro J; Kalwinsky DK; Ayers GD; Behm FG
Blood; 1992 Dec; 80(12):3182-8. PubMed ID: 1467524
[TBL] [Abstract][Full Text] [Related]
17. Molecular cytogenetic findings in a three-way novel variant of t(1;8;21)(p35;q22;q22): a unique relocation of the AML1/ETO fusion gene 1p35 in AML-M2.
Ahmad F; Kokate P; Chheda P; Dalvi R; Das BR; Mandava S
Cancer Genet Cytogenet; 2008 Jan; 180(2):153-7. PubMed ID: 18206543
[TBL] [Abstract][Full Text] [Related]
18. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and biological characteristics in childhood acute myeloid leukemia with 8;21 translocation].
He J; Xue Y; He H; Li J; Song X; Huang Y; He Y; Zhang X; Chai Y; Zhu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):512-4. PubMed ID: 15476184
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloblastic leukemia (ANLL-M2) with t(8;21)(q22;q22) variant expressing lymphoid but not myeloid surface antigens with a high number of G-CSF receptors.
Tsuchiya H; ElSonbaty SS; Nagano K; Watanabe M; Migita M; Mitsubuchi H; Kaneko Y; Matsuda I
Leuk Res; 1993 Apr; 17(4):375-7. PubMed ID: 8487587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
